Serum S100A12 concentrations were greater in the IBD group compared to the non-IBD group (median 196 (27–14,810) ng/mL versus median 82 (15–4242) ng/mL, P < 0.01). This evidence concerns the gene S100A12 and irritable bowel syndrome.